Publication: Identification of a Selective Small Molecule Inhibitor of Breast Cancer Stem Cells
Loading...
Date
2012
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier BV
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Germain, Andrew R., Leigh C. Carmody, Barbara Morgan, Cristina Fernandez, Erin Forbeck, Timothy A. Lewis, Partha P. Nag, et al. 2012. “Identification of a Selective Small Molecule Inhibitor of Breast Cancer Stem Cells.” Bioorganic & Medicinal Chemistry Letters 22 (10) (May): 3571–3574. doi:10.1016/j.bmcl.2012.01.035. http://dx.doi.org/10.1016/j.bmcl.2012.01.035.
Abstract
A high-throughput screen (HTS) with the National Institute of Health–Molecular Libraries Small Molecule Repository (NIH–MLSMR) compound collection identified a class of acyl hydrazones to be selectively lethal to breast cancer stem cell (CSC) enriched populations. Medicinal chemistry efforts were undertaken to optimize potency and selectivity of this class of compounds. The optimized compound was declared as a probe (ML239) with the NIH Molecular Libraries Program and displayed greater than 20-fold selective inhibition of the breast CSC-like cell line (HMLE_sh_Ecad) over the isogenic control line (HMLE_sh_GFP).
Description
Other Available Sources
Research Data
Keywords
cancer stem cells, breast cancer
Terms of Use
Metadata Only